HCA — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates HCA as Neutral with 78% confidence in the Healthcare sector.
AI Analysis Summary
HCA presents significant risks due to high debt, weak liquidity, and bearish technicals, outweighing its market position and free cash flow yield.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 45/100
- Bill Ackman (Activist Investing): Grade B — 67/100
- Ray Dalio (Macro/Risk Parity): Grade D — 35/100
Consensus: Bearish
Price Intelligence
- Current price: $445.77
- Price target: $393.38 (-11.8%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
HCA is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.